Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
CUSIP: 22663K107
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 94,401,153
- Total 13F shares
- 33,632,624
- Share change
- +759,575
- Total reported value
- $708,150,662
- Price per share
- $21.05
- Number of holders
- 91
- Value change
- +$17,177,215
- Number of buys
- 49
- Number of sells
- 25
Quarterly Holders Quick Answers
What is CUSIP 22663K107?
CUSIP 22663K107 identifies CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22663K107:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
5.4%
|
5,118,948
|
$96,492,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.2%
|
3,963,517
|
$74,712,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.2%
|
2,996,876
|
$56,491,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.9%
|
2,707,825
|
$51,043,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
2,593,386
|
$48,885,000 | — | 30 Jun 2021 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.15%
|
141,000
|
$44,282,000 | — | 30 Jun 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
1.9%
|
1,752,346
|
$33,032,000 | — | 30 Jun 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.8%
|
1,679,701
|
$31,662,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
1,502,837
|
$28,328,000 | — | 30 Jun 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.4%
|
1,362,286
|
$25,679,000 | — | 30 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.98%
|
920,656
|
$17,354,000 | — | 30 Jun 2021 | |
| Versant Venture Management, LLC |
13F
|
Company |
0.87%
|
820,720
|
$15,471,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.79%
|
745,387
|
$14,051,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.75%
|
708,133
|
$13,348,000 | — | 30 Jun 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.67%
|
634,088
|
$11,953,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
546,432
|
$10,300,000 | — | 30 Jun 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.56%
|
533,033
|
$10,048,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
508,821
|
$9,591,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
366,114
|
$6,900,000 | — | 30 Jun 2021 | |
| Burrage Capital Management LLC |
13F
|
Company |
0.31%
|
294,620
|
$5,554,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
292,155
|
$5,507,000 | — | 30 Jun 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.26%
|
243,309
|
$4,586,000 | — | 30 Jun 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.21%
|
200,500
|
$3,779,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
195,921
|
$3,694,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
185,293
|
$3,493,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
181,997
|
$3,430,000 | — | 30 Jun 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.18%
|
166,317
|
$3,135,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
148,349
|
$2,796,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
116,310
|
$2,192,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.09%
|
89,086
|
$1,679,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
85,000
|
$1,602,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.08%
|
79,618
|
$1,501,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.08%
|
72,800
|
$1,372,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.07%
|
65,925
|
$1,243,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
60,805
|
$1,147,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
60,658
|
$1,144,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
50,354
|
$949,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
49,600
|
$935,000 | — | 30 Jun 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.05%
|
49,516
|
$933,000 | — | 30 Jun 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.05%
|
43,671
|
$824,000 | — | 30 Jun 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
38,600
|
$728,000 | — | 30 Jun 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
33,551
|
$632,000 | — | 30 Jun 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
31,522
|
$594,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.03%
|
31,232
|
$589,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
29,500
|
$556,000 | — | 30 Jun 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.03%
|
27,839
|
$525,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
0.03%
|
24,280
|
$458,000 | — | 30 Jun 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
21,800
|
$411,000 | — | 30 Jun 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
21,800
|
$411,000 | — | 30 Jun 2021 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.02%
|
18,600
|
$388,000 | — | 30 Jun 2021 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q3 2021
As of 30 Sep 2021,
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,632,624 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, 5AM Venture Management, LLC, STATE STREET CORP, and BVF INC/IL.
This page lists
91
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
81
Q3 2021 holders
91
Holder diff
10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.